Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Chemotherapy|November 1, 2023
Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type: A Case ReportSabrina Zoli, Cinzia Pellegrini, Beatrice Casadei, et al.
Journal of Clinical Medicine|December 24, 2021
Long-Term Efficacy and Safety of Ibrutinib in the Treatment of CLL Patients: A Real Life ExperienceAlessandro Broccoli, Lisa Argnani, Alice Morigi, et al.
Chemotherapy|June 13, 2023
Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case ReportMarianna Gentilini, Beatrice Casadei, Alice Morigi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 15, 2024
Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patientsGianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, et al.
Oncotargets and Therapy|July 30, 2019
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemiaAlessandro Broccoli, Clara Bertuzzi, Michelangelo Fiorentino, et al.
The Oncologist|February 10, 2024
The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous TransplantationAlessandro Broccoli, Lisa Argnani, Gabriele Gugliotta, et al.
The Oncologist|August 4, 2016
Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma PatientsLetizia Gandolfi, Cinzia Pellegrini, Beatrice Casadei, et al.
Hematological Oncology|July 3, 2014
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patientsPier Luigi Zinzani, Cinzia Pellegrini, Alessandro Broccoli, et al.
Annals of Surgery|November 14, 2025
The CONVERSION Study: Open Conversion Risk in Robotic vs Laparoscopic Surgery-A 20-Year Meta-analysisAntonio Gangemi, Amir Ebadinejad, Anthony P Lisi, et al.
Annals of Hematology|April 23, 2014
Is it really possible to cure hairy cell leukemia patients only with frontline therapy?Pier Luigi Zinzani, Vittorio Stefoni, Alessandro Broccoli, et al.
Pageof 10